Insights Into Health Catalyst Inc (HCAT) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Health Catalyst Inc is listed on the NASDAQ in the Healthcare sector while operating in the Health Information Services industry. The current market capitalization of Health Catalyst Inc is $352.91M. A total of 0.59 million shares were traded on the day, compared to an average of 624.66K shares.

In the most recent transaction, Llewelyn Linda sold 6,442 shares of HCAT for 5.80 per share on Jan 15 ’25. After the transaction, the Chief People Officer now owns 92,260 company shares. In a previous transaction on Jan 15 ’25, LINDA LLEWELYN bought 6,442 shares at 5.90 per share.

Among the insiders who sold shares, LeSueur Daniel disposed of 5,209 shares on Jan 06 ’25 at a per-share price of $7.51. This resulted in the Chief Operating Officer holding 91,253 shares of HCAT after the transaction. In another insider transaction, Landry Benjamin sold 2,500 shares at $7.52 per share on Jan 06 ’25. Company shares held by the General Counsel now total 72,250.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, HCAT has a high of $10.78 and a low of $5.35.

As of this writing, HCAT has an earnings estimate of $0.08 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $0.15 per share and a lower estimate of $0.03.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. HCAT’s latest balance sheet shows that the firm has $444.98M in Cash & Short Term Investments as of fiscal 2021. There were $204.61M in debt and $93.05M in liabilities at the time. Its Book Value Per Share was $5.83, while its Total Shareholder’s Equity was $522.10M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HCAT is Buy with a score of 4.47.

Most Popular

Related Posts